Sean Wieland

Stock Analyst at Piper Sandler

(1.32)
# 1977
Out of 5,441 analysts
51
Total ratings
Success rate
Average return
17 Stocks
Name Action PT Current % Upside Ratings Updated
OMCL Omnicell
Maintains: Overweight
57 55
30.85 78.28% 11 Aug 11, 2025
PRVA Privia Health Gr
Maintains: Overweight
35 36
20.31 77.25% 3 Aug 11, 2025
AMWL American Well
Maintains: Overweight
100 120
7.13 1583.03% 2 Jun 23, 2022
HIMS Hims & Hers Health
Maintains: Overweight
8 6
49.96 -87.99% 3 May 26, 2022
DOCS Doximity
Maintains: Overweight
81 44
61.88 -28.89% 2 May 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
34 27
30.49 -11.45% 2 Mar 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 20
16.47 21.43% 5 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
261 231
180.09 28.27% 4 Feb 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
68 80
79.13 0.15% 4 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
305 291
6.78 4192.04% 5 Feb 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
40 41
10.5 290.48% 2 Feb 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
55 143
n/a n/a 3 Oct 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
54
39 38.46% 1 Aug 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
45
7.02 541.03% 1 Jul 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25
32.5 -23.08% 1 Jan 27, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 13, 2016